XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2023
Disaggregation of Revenue [Line Items]  
Schedule of Condensed Income Statement by Segment

Condensed Statements of Operations

Three Months Ended June 30, 2023

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

2,237

$

248

$

117

$

13

$

46

$

23

$

$

2,684

Other revenues from operations

 

 

 

177

 

 

20

 

 

1

 

 

198

Net loss from investment activities

 

(500)

 

 

 

 

 

 

 

 

(500)

Interest and dividend income

 

134

 

8

 

 

 

 

 

 

25

 

167

Other (loss) income, net

 

(18)

 

3

 

3

 

1

 

1

 

 

1

 

 

(9)

 

(384)

 

2,248

 

428

 

118

 

34

 

46

 

25

 

25

 

2,540

Expenses:

Cost of goods sold

 

 

1,990

 

173

 

90

 

8

 

35

 

14

 

 

2,310

Other expenses from operations

 

 

 

142

 

 

18

 

 

 

 

160

Selling, general and administrative

 

13

 

39

 

114

 

15

 

5

 

10

 

11

 

8

 

215

Credit loss on related party note receivable

 

 

 

 

 

 

 

 

116

 

116

Loss on deconsolidation of subsidiaries

20

20

Interest expense

 

38

 

22

 

1

 

3

 

 

 

 

72

 

136

 

51

 

2,051

 

430

 

108

 

31

 

45

 

25

 

216

 

2,957

(Loss) income before income tax (expense) benefit

 

(435)

 

197

 

(2)

 

10

 

3

 

1

 

 

(191)

 

(417)

Income tax (expense) benefit

 

 

(41)

 

6

 

(5)

 

 

 

 

38

 

(2)

Net (loss) income

 

(435)

 

156

 

4

 

5

 

3

 

1

 

 

(153)

 

(419)

Less: net (loss) income attributable to non-controlling interests

 

(220)

 

70

 

 

 

 

 

 

 

(150)

Net (loss) income attributable to Icahn Enterprises

$

(215)

$

86

$

4

$

5

$

3

$

1

$

$

(153)

$

(269)

Supplemental information:

Capital expenditures

$

$

56

$

11

$

5

$

$

1

$

$

$

73

Depreciation and amortization

$

$

89

$

22

$

7

$

3

$

1

$

7

$

$

129

Three Months Ended June 30, 2022

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

3,144

$

438

$

110

$

17

$

69

$

18

$

$

3,796

Other revenues from operations

 

 

 

183

 

 

13

 

 

1

 

 

197

Net (loss) from investment activities

 

(459)

 

 

 

 

 

 

 

17

 

(442)

Interest and dividend income

 

47

 

1

 

 

 

 

 

 

2

 

50

Other (loss) income, net

 

(18)

 

(75)

 

 

(6)

 

 

 

 

1

 

(98)

 

(430)

 

3,070

 

621

 

104

 

30

 

69

 

19

 

20

 

3,503

Expenses:

Cost of goods sold

 

 

2,715

 

288

 

90

 

12

 

57

 

12

 

 

3,174

Other expenses from operations

 

 

 

134

 

 

14

 

 

 

 

148

Selling, general and administrative

 

10

 

43

 

219

 

13

 

3

 

11

 

10

 

6

 

315

Restructuring, net

 

 

 

 

 

 

 

 

 

Interest expense

 

53

 

24

 

 

2

 

 

1

 

 

71

 

151

 

63

 

2,782

 

641

 

105

 

29

 

69

 

22

 

77

 

3,788

(Loss) income before income tax (expense) benefit

 

(493)

 

288

 

(20)

 

(1)

 

1

 

 

(3)

 

(57)

 

(285)

Income tax (expense) benefit

 

 

(61)

 

5

 

(2)

 

 

 

 

56

 

(2)

Net (loss) income

 

(493)

 

227

 

(15)

 

(3)

 

1

 

 

(3)

 

(1)

 

(287)

Less: net (loss) income attributable to non-controlling interests

 

(275)

 

117

 

 

(1)

 

 

 

 

 

(159)

Net (loss) income attributable to Icahn Enterprises

$

(218)

$

110

$

(15)

$

(2)

$

1

$

$

(3)

$

(1)

$

(128)

Supplemental information:

Capital expenditures

$

$

62

$

30

$

5

$

2

$

$

$

$

99

Depreciation and amortization

$

$

89

$

20

$

7

$

3

$

1

$

7

$

$

127

Six Months Ended June 30, 2023

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

4,523

$

535

$

235

$

20

$

86

$

43

$

$

5,442

Other revenues from operations

 

 

 

347

 

 

36

 

 

2

 

 

385

Net loss from investment activities

 

(943)

 

 

 

 

 

 

 

 

(943)

Interest and dividend income

 

278

 

13

 

 

 

 

 

 

47

 

338

Other (loss) income, net

 

(46)

 

6

 

3

 

(6)

 

1

 

 

1

 

 

(41)

 

(711)

 

4,542

 

885

 

229

 

57

 

86

 

46

 

47

 

5,181

Expenses:

Cost of goods sold

 

 

3,916

 

366

 

181

 

14

 

67

 

26

 

 

4,570

Other expenses from operations

 

 

 

287

 

 

31

 

 

 

 

318

Selling, general and administrative

 

16

 

85

 

246

 

29

 

9

 

20

 

24

 

15

 

444

Credit loss on related party note receivable

 

 

 

 

 

 

 

 

116

 

116

Loss on deconsolidation of subsidiary

246

246

Interest expense

 

83

 

45

 

1

 

6

 

 

 

 

143

 

278

 

99

 

4,046

 

900

 

216

 

54

 

87

 

50

 

520

 

5,972

(Loss) before income tax (expense) benefit

 

(810)

 

496

 

(15)

 

13

 

3

 

(1)

 

(4)

 

(473)

 

(791)

Income tax (expense) benefit

 

 

(93)

 

6

 

(1)

 

 

 

 

102

 

14

Net (loss) income

 

(810)

 

403

 

(9)

 

12

 

3

 

(1)

 

(4)

 

(371)

 

(777)

Less: net (loss) income attributable to non-controlling interests

 

(424)

 

185

 

 

1

 

 

 

 

 

(238)

Net (loss) income attributable to Icahn Enterprises

$

(386)

$

218

$

(9)

$

11

$

3

$

(1)

$

(4)

$

(371)

$

(539)

Supplemental information:

Capital expenditures

$

$

100

$

21

$

7

$

2

$

1

$

$

$

131

Depreciation and amortization

$

$

173

$

41

$

14

$

6

$

3

$

14

$

$

251

Six Months Ended June 30, 2022

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

 

Consolidated

(in millions)

 

Revenues:

    

  

  

  

  

  

  

  

  

 

  

Net sales

$

$

5,517

$

845

$

211

$

34

$

124

$

33

$

$

6,764

Other revenues from operations

 

 

 

339

 

 

24

 

 

2

 

 

365

Net gain from investment activities

 

449

 

 

 

 

 

 

 

48

 

497

Interest and dividend income

 

87

 

1

 

 

 

 

 

 

4

 

92

Other (loss) income, net

 

(35)

 

(85)

 

2

 

(5)

 

 

 

1

 

 

(122)

 

501

 

5,433

 

1,186

 

206

 

58

 

124

 

36

 

52

 

7,596

Expenses:

 

Cost of goods sold

 

 

4,838

 

555

 

171

 

22

 

102

 

24

 

 

5,712

Other expenses from operations

 

 

 

260

 

 

25

 

 

 

 

285

Selling, general and administrative

 

14

 

88

 

427

 

26

 

7

 

22

 

20

 

12

 

616

Interest expense

 

85

 

48

 

1

 

3

 

 

1

 

 

147

 

285

 

99

 

4,974

 

1,243

 

200

 

54

 

125

 

44

 

159

 

6,898

Income (loss) before income tax benefit (expense)

 

402

 

459

 

(57)

 

6

 

4

 

(1)

 

(8)

 

(107)

 

698

Income tax (expense) benefit

 

 

(91)

 

14

 

(3)

 

 

 

 

(20)

 

(100)

Net income (loss)

 

402

 

368

 

(43)

 

3

 

4

 

(1)

 

(8)

 

(127)

 

598

Less: net income attributable to non-controlling interests

 

206

 

197

 

 

 

 

 

 

 

403

Net income (loss) attributable to Icahn Enterprises

$

196

$

171

$

(43)

$

3

$

4

$

(1)

$

(8)

$

(127)

$

195

Supplemental information:

 

Capital expenditures

$

$

88

$

51

$

9

$

6

$

$

$

$

154

Depreciation and amortization

$

$

172

$

40

$

14

$

6

$

3

$

14

$

$

249

Schedule of Condensed Financial Statements by Segment

June 30, 2023

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

22

$

751

$

59

$

7

$

46

$

5

$

24

$

1,574

$

2,488

Cash held at consolidated affiliated partnerships and restricted cash

 

2,401

 

7

 

9

 

 

7

 

3

 

 

171

 

2,598

Investments

 

4,821

 

102

 

 

 

14

 

 

 

 

4,937

Accounts receivable, net

 

 

300

 

39

 

90

 

15

 

27

 

24

 

 

495

Inventories, net

 

 

524

 

260

 

111

 

 

90

 

30

 

 

1,015

Related party notes receivable

82

82

Property, plant and equipment, net

 

 

2,630

 

792

 

137

 

341

 

54

 

 

5

 

3,959

Goodwill and intangible assets, net

 

 

189

 

346

 

24

 

 

19

 

212

 

 

790

Other assets

 

4,644

 

298

 

469

 

104

 

96

 

17

 

5

 

217

 

5,850

Total assets

$

11,888

$

4,801

$

1,974

$

473

$

519

$

215

$

295

$

2,049

$

22,214

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

1,637

$

1,727

$

847

$

140

$

53

$

44

$

58

$

73

$

4,579

Securities sold, not yet purchased, at fair value

 

3,370

 

 

 

 

 

 

 

 

3,370

Debt

 

 

1,591

 

19

 

150

 

1

 

9

 

 

5,308

 

7,078

Total liabilities

 

5,007

 

3,318

 

866

 

290

 

54

 

53

 

58

 

5,381

 

15,027

Equity attributable to Icahn Enterprises

 

3,799

 

795

 

1,108

 

166

 

461

 

162

 

237

 

(3,332)

 

3,396

Equity attributable to non-controlling interests

 

3,082

 

688

 

 

17

 

4

 

 

 

 

3,791

Total equity

 

6,881

 

1,483

 

1,108

 

183

 

465

 

162

 

237

 

(3,332)

 

7,187

Total liabilities and equity

$

11,888

$

4,801

$

1,974

$

473

$

519

$

215

$

295

$

2,049

$

22,214

December 31, 2022

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

19

$

510

$

32

$

9

$

26

$

5

$

16

$

1,720

$

2,337

Cash held at consolidated affiliated partnerships and restricted cash

 

2,455

 

7

 

10

 

 

8

 

3

 

 

66

 

2,549

Investments

 

6,719

 

76

 

 

 

14

 

 

 

 

6,809

Accounts receivable, net

 

 

358

 

99

 

87

 

12

 

24

 

26

 

 

606

Inventories, net

 

 

624

 

686

 

103

 

 

90

 

28

 

 

1,531

Property, plant and equipment, net

 

 

2,664

 

826

 

142

 

345

 

56

 

 

5

 

4,038

Goodwill and intangible assets, net

 

 

200

 

352

 

24

 

 

19

 

226

 

 

821

Other assets

 

8,041

 

296

 

527

 

110

 

102

 

16

 

6

 

125

 

9,223

Total assets

$

17,234

$

4,735

$

2,532

$

475

$

507

$

213

$

302

$

1,916

$

27,914

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

1,589

$

1,823

$

981

$

149

$

47

$

45

$

61

$

70

$

4,765

Securities sold, not yet purchased, at fair value

 

6,495

 

 

 

 

 

 

 

 

6,495

Debt

 

 

1,591

 

21

 

162

 

1

 

12

 

 

5,309

 

7,096

Total liabilities

 

8,084

 

3,414

 

1,002

 

311

 

48

 

57

 

61

 

5,379

 

18,356

Equity attributable to Icahn Enterprises

 

4,184

 

648

 

1,530

 

149

 

455

 

156

 

241

 

(3,463)

 

3,900

Equity attributable to non-controlling interests

 

4,966

 

673

 

 

15

 

4

 

 

 

 

5,658

Total equity

 

9,150

 

1,321

 

1,530

 

164

 

459

 

156

 

241

 

(3,463)

 

9,558

Total liabilities and equity

$

17,234

$

4,735

$

2,532

$

475

$

507

$

213

$

302

$

1,916

$

27,914

Energy Segment  
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2023

    

2022

    

2023

    

2022

(in millions)

Petroleum products

$

2,054

$

2,900

$

4,114

$

5,050

Nitrogen fertilizer products

 

183

 

244

 

409

 

467

$

2,237

$

3,144

$

4,523

$

5,517

Automotive Segment  
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2023

    

2022

    

2023

    

2022

(in millions)

Automotive services

$

392

$

393

$

761

$

746

Aftermarket parts sales

 

20

 

215

 

92

 

416

$

412

$

608

$

853

$

1,162